Is Y90 Radioembolization Superior or Comparable to Transarterial Chemoembolization for Treating Hepatocellular Carcinoma?

被引：3
|
作者：
Pan, Ling-Hui [1 ]
Zhao, Chang [2 ]
Ma, Yi-Long [2 ]
机构：
[1] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Anesthesiol, Nanning, Peoples R China
[2] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Invas Technol, Nanning, Peoples R China
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 06期
基金：
中国国家自然科学基金;
关键词：
HEPATIC RESECTION;
D O I：
10.1053/j.gastro.2016.10.048
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1627 / +
页数：2
相关论文
共 50 条
  • [41] 90Y radioembolization versus chemoembolization in the treatment of hepatocellular carcinoma: an analysis of comparative effectiveness
    Xing, Minzhi
    Kokabi, Nima
    Camacho, Juan C.
    Kooby, David A.
    El-Rayes, Bassel F.
    Kim, Hyun S.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2013, 2 (04) : 435 - 444
  • [42] Increased Voxel-Based Y90 Radioembolization Dose to Hepatocellular Carcinoma Improves Imaging Response
    Srinivas, Shanmukha
    Pianka, Kurt
    Rockwell, Helena D.
    Yeluru, Akhilesh
    Liau, Joy
    Ganesh, Ashwin
    Minocha, Jeet
    Mcnamee, Cairine
    Rose, Steven C.
    Fowler, Kathryn
    Berman, Zachary T.
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2025,
  • [43] Chemoembolization and Radioembolization for Hepatocellular Carcinoma
    Salem, Riad
    Lewandowski, Robert J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (06) : 604 - 611
  • [44] PREVIOUS EMBOLIZING TREATMENTS FOR HEPATOCELLULAR CARCINOMA DO NOT AFFECT CLINICAL OUTCOMES AFTER Y90 RADIOEMBOLIZATION
    Inarrairaegui, Mercedes
    Bilbao, Jose I.
    Benito, Alberto
    Rodriguez, Macarena
    D'Avola, Delia
    Quiroga, Jorge
    Ignacio Herrero, Jose
    Sangro, Bruno
    HEPATOLOGY, 2010, 52 (04) : 1196A - 1196A
  • [45] Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma:a systematic review and meta-analysis
    Yi Yang
    Tongguo Si
    Cancer Biology & Medicine, 2018, (03) : 299 - 310
  • [46] Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma: a systematic review and meta-analysis
    Yang, Yi
    Si, Tongguo
    CANCER BIOLOGY & MEDICINE, 2018, 15 (03) : 299 - 310
  • [47] SORAFENIB VERSUS RADIOEMBOLIZATION WITH Y90: CLINICAL EVALUATION AND SURVIVAL IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA AND CIRRHOSIS
    Gaia, S.
    Tabone, M.
    Cantamessa, A.
    Campion, D.
    Carucci, P.
    Grosso, M.
    Risso, A.
    Brunocilla, P. R.
    Calvo, A.
    Brunello, F.
    Rizzetto, M.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S109 - S110
  • [48] Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma:a systematic review and meta-analysis
    Yi Yang
    Tongguo Si
    Cancer Biology & Medicine, 2018, 15 (03) : 299 - 310
  • [49] Cost Effectiveness of Radioembolization Compared with Conventional Transarterial Chemoembolization for Treatment of Hepatocellular Carcinoma
    Rostambeigi, Nassir
    Dekarske, Adrienne S.
    Austin, Erin E.
    Golzarian, Jafar
    Cressman, Erik N.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2014, 25 (07) : 1075 - 1084
  • [50] Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?
    Benkoe, Tamas
    Koenig, Julia
    Theysohn, Jens M.
    Schotten, Clemens
    Saner, Fuat H.
    Treckmann, Juergen
    Radunz, Sonia
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2022, 27 (01)
12345